I think that’s way to conservative $15-$20 based

I think that’s way to conservative $15-$20 based on first year sales in the 5-8 billion revenue. Covid isn’t going anywhere all the new strains along Haulers therapeutic will be the number 1 most needed therapeutic HUGE market after leronlimab takes care of the most at risk of mortality in the severe critical stages. Conservative PE ratio would but this at $35-$40 and that doesn’t include the portion of HIV 30 billion dollar yearly market that CYDY would be taking a big chunk of, also doesn’t factor in the 20+ other indications that show promise and the fact that all trials are able to start in phase 2 skipping phase 1 saving endless amounts of time and money also the fact that CYDY will not have to spend 10’s millions dollars to advertise there first drug to market tagt will bring in billions while spending close to nothing on marketing.